Latest publications

Carbonaceous particle exposure contributes to chronic lung disease development 10 March 2025

A recent study by nanoPASS partner Helmholtz Munich, led by Lianyong Han, Verena Haefner, Ali Önder Yildirim, Heiko Adler, and Tobias Stoeger, explores the role of carbonaceous particle exposure in...

December 2024 Newsletter 11 December 2024

The latest nanoPASS newsletter reflects on key achievements and advancements in nanosafety over the past six months. Highlights include groundbreaking research on environmental triggers for Alzheimer’s disease, insights into nanoparticle...

NPCoronaPredict: A Computational Pipeline for the Prediction of the Nanoparticle–Biomolecule Corona 14 November 2024

In a recent Journal of Chemical Information and Modeling article, Ian Rouse, David Power, Julia Subbotina, and Vladimir Lobaskin from University College Dublin present new computational models to predict nanoparticle...

Acute, controlled inhalation of thin graphene oxide nanosheets in humans with null cardiorespiratory effects 14 November 2024

In a recent Nature Nanotechnology article, Ulla Vogel from the National Research Centre for the Working Environment (NFA) examines the complex ways nanoparticles interact with the immune system, underscoring both...

The eATP/P2×7R Axis Drives Quantum Dot-Nanoparticle Induced Neutrophil Recruitment in the Pulmonary Microcirculation 14 November 2024

A new study from Helmholtz Munich scientists, Markus Rehberg and Tobias Stoeger, partners in the nanoPASS project, reveals how certain nanoparticles can impact our lungs’ immune response. Published in Advanced...

June 2024 Project Newsletter 14 November 2024

Discover the latest developments in the nanoPASS project, including key advancements and insights from our mid-year activities. This issue covers recent progress, collaborations, and our focus areas for the coming...

AOPs 33: Substance interaction with the pulmonary resident cell membrane components leading to pulmonary fibrosis 14 November 2024

The first nanomaterial-relevant Adverse Outcome Pathway (AOP) has been endorsed by the OECD, which is now referred to as AOPs 33 (formerly known as AOP173). AOPs 33 on ‘Substance interaction...

December 2023 Project Newsletter 14 November 2024

Catch up on the latest nanoPASS project updates and insights as we wrap up the year! In this issue, you'll find highlights on recent project milestones, progress in our research,...

Computational modelling of bionano interface 14 November 2024

AbstractThe interface between inorganic and biological materials plays a crucial role in vital technological applications ranging from food processing and cosmetics to medicine but presents enormous technical challenges for computational...

Welcome to nanoPASS: First newsletter 14 November 2024

Our first newsletter is out! Find out what we have been up to for the first few months of the project and discover what is coming up. Read the full...

Particulate Matter Constituents Trigger the Formation of Extracellular Amyloid β and Tau-containing Plaques and Neurite Shortening In Vitro 14 November 2024

AbstractAir pollution is an environmental factor associated with an increased risk of neurodegenerative diseases, such as Alzheimer’s and Parkinson’s, characterized by decreased cognitive abilities and memory. The limited models of...